NASDAQ:XENE - Xenon Pharmaceuticals Price Target & Analyst Ratings

$10.02
+0.02 (+0.20 %)
(As of 07/19/2019 04:00 PM ET)
Today's Range
$9.83
Now: $10.02
$10.32
50-Day Range
$8.96
MA: $9.87
$10.65
52-Week Range
$5.41
Now: $10.02
$15.92
Volume29,656 shs
Average Volume54,333 shs
Market Capitalization$258.22 million
P/E RatioN/A
Dividend YieldN/A
Beta1.33

Analyst Ratings

Xenon Pharmaceuticals (NASDAQ:XENE) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Xenon Pharmaceuticals in the last 12 months. Their average twelve-month price target is $17.00, suggesting that the stock has a possible upside of 69.66%. The high price target for XENE is $18.00 and the low price target for XENE is $16.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $17.00$17.00$17.00$15.50
Price Target Upside: 69.66% upside76.53% upside76.53% upside31.91% upside

Xenon Pharmaceuticals (NASDAQ:XENE) Consensus Price Target History

Xenon Pharmaceuticals (NASDAQ:XENE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/29/2019Stifel NicolausReiterated RatingBuy$21.00 ➝ $18.00HighView Rating Details
8/10/2018Jefferies Financial GroupReiterated RatingBuy$16.00LowView Rating Details
(Data available from 7/20/2017 forward)
This page was last updated on 7/20/2019 by MarketBeat.com Staff

Featured Article: Institutional Investors

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel